Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:05:03.226Z.
Calculation as of: 2026-10-06T18:05:03.226Z.
Quote observation: 2026-10-06T18:00:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 371c12db8760855cbd67a4f629ef705ee3b50919edbb0a0fc68f9f6d9159db17
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $164.58M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $164.96M | N/A | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $167.42M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.49M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.73M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $157.59M | N/A | N/A | N/A | N/A |
| PepGen Inc. (PEPG)vs › | $158.74M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $157.57M | N/A | 2.79 | 2.79 | 2.79 |
| Cue Biopharma, Inc. (CUE)vs › | $172.02M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute